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Background: The arterial partial pressure of O2 and the fraction of inspired oxygen (PaO2/FiO2) ratio is widely used
in ICUs as an indicator of oxygenation status. Although cardiac surgery and ICU scores can predict mortality, during
the first hours after cardiac surgery few instruments are available to assess outcome. The aim of this study was to
evaluate the usefulness of PaO2/FIO2 ratio to predict mortality in patients immediately after cardiac surgery.
Methods: We prospectively studied 2725 consecutive cardiac surgery patients between 2004 and 2009. PaO2/FiO2
ratio was measured on admission and at 3 h, 6 h, 12 h and 24 h after ICU admission, together with clinical data
and outcomes.
Results: All PaO2/FIO2 ratio measurements differed between survivors and non-survivors (p < 0.001). The PaO2/FIO2
at 3 h after ICU admission was the best predictor of mortality based on area under the curve (p < 0.001) and the
optimum threshold estimation gave an optimal cut-off of 222 (95% Confidence interval (CI): 202–242), yielding three
groups of patients: Group 1, with PaO2/FIO2 > 242; Group 2, with PaO2/FIO2 from 202 to 242; and Group 3, with
PaO2/FIO2 < 202. Group 3 showed higher in-ICU mortality and ICU length of stay and Groups 2 and 3 also showed
higher respiratory complication rates. The presence of a PaO2/FIO2 ratio < 202 at 3 h after admission was shown to
be a predictor of in-ICU mortality (OR:1.364; 95% CI:1.212-1.625, p < 0.001) and of worse long-term survival (88.8% vs.
95.8%; Log rank p = 0.002. Adjusted Hazard ratio: 1.48; 95% CI:1.293–1.786; p = 0.004).
Conclusions: A simple determination of PaO2/FIO2 at 3 h after ICU admission may be useful to identify patients at
risk immediately after cardiac surgery.
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In critically ill patients the PaO2/FIO2 ratio is an indica-
tor of oxygenation status and is one of the diagnostic
criteria for acute respiratory distress syndrome in adults
(ARDS) [1-4]. A low PaO2/FiO2 value has been associ-
ated with increased mortality and hospital stay in pa-
tients admitted to the intensive care unit (ICU) [5-8].
The PaO2/FiO2 ratio is widely used in ICUs because it* Correspondence: juancarloslopezde@hotmail.com
1Intensive Care Department, Hospital Universitari de Bellvitge, IDIBELL
(Institut d’Investigació Biomèdica Bellvitge; Biomedical Investigation Institute
of Bellvitge), C/Feixa Llarga s/n. 08907L’Hospitalet de Llobregat, Barcelona,
Spain
Full list of author information is available at the end of the article
© 2014 Esteve et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.quickly and easily provides data on the oxygenation sta-
tus of critically ill patients. Its values are included in
ICU prognostic scores [9,10]. During surgery, atelectasis
may cause intraoperative gas exchange abnormalities,
which may be increased by inflammation triggered by
the surgery itself, leading to postoperative lung dysfunc-
tion even in patients without preexisting lung injury.
Despite protective mechanical ventilation during and
after surgery, including recruitment maneuvers, a lower
PaO2/FiO2 may be a reflection of a persistent lung dys-
function which can influence outcome [11].
The population of patients who undergo cardiac sur-
gery is heterogeneous. With the trend towards greaterLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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higher rates of comorbidities such as chronic heart or
respiratory failure [12]. The cardiac surgery scores
habitually used to predict short-term postoperative
mortality (Parsonnet, European System for Cardiac Op-
erative Risk Evaluation (EuroSCORE)) are objective and
relatively simple [13,14]; however, they evaluate pre-
operative status and may become inaccurate in the case
of surgical complications. ICU scores (Acute Physiology
and Chronic Health Evaluation (APACHE) II and III,
Simplified Acute Physiology Score (SAPS) II and III)
[9,10] are not specific for cardiac surgery and both re-
quire 24 hours for calculation. Other than their clinical
judgment, physicians have few tools available for asses-
sing outcome immediately after cardiac surgery.
The aim of this study was to evaluate the usefulness of
the PaO2/FIO2 ratio for predicting mortality in patients
after cardiac surgery in order to provide a potential tool
and value for immediate postoperative assessment. We
also aimed to test the value of the PaO2/FIO2 ratio to
assess respiratory complications.Methods
A prospective single-center observational study was con-
ducted in a 10-bed cardiac surgery ICU at a 900-bed refer-
ral university hospital. The data were collected between
January 2004 and January 2009. During the study period
2725 consecutive patients underwent various types of car-
diac surgery. PaO2/FIO2 ratios after ICU admission were
obtained for 2701 patients and these data were used for the
subsequent analysis. Heart-transplant patients (n = 98) were
not included, due to their particular physiopathology.
The local clinical research ethics committee (Comité
d’Ètica i Assajos Clínics de Hospital Universitari de Bell-
vitge) approved the study protocol. Informed consent
was waived because of the observational nature of the
study and because all procedures were routine.
The PaO2/FiO2 ratio was measured at ICU admission,
and after 3 h, 6 h, 12 h and 24 h, together with clinical
data and outcomes. Data on and during ICU admission
were extracted from the medical registry of each patient
in real time using a standardized questionnaire and
stored in a database for analysis. The definitions used
for this study were based on the Society of Thoracic
Surgeons’ national cardiac surgery database definitions
[15]. In all the patients admitted to our cardiac surgery
ICU we recorded demographic data (including risk factors
for cardiovascular disease), diagnostic category, preopera-
tive conditions, type of surgery (valvular, coronary or both)
and characteristics (cardiopulmonary bypass (CBP) and
aortic clamping times), respiratory complications, length of
ICU and hospital stay, and mortality in the ICU and hos-
pital. Outcome scores were also calculated for each patient:cardiac surgery scores (Parsonnet and EuroSCORE) and
ICU scores (APACHE II and III, and SAPS II).
Both the clinical and laboratory data obtained are based
on the internal postoperative protocol in place when this
study was performed. Arterial blood gas analyses were
performed at our hospital’s local laboratory, which meets
the International Organization for Standardization quality
standards (ISO 9001:2000).
The operations were performed by the same group of
cardiac surgeons. Cardiac procedures were performed in
all patients using median sternotomy, standard CPB with
moderate hypothermia (34°C) and antegrade cardioplegia.
A mean aortic pressure of > 60 mmHg was maintained
during surgery. Intraoperative ventilatory strategies were
based on an individual approach according to the patient’s
previous respiratory status. Volume-controlled ventilation
with a tidal volume of around 8 mL · kg−1 and a minimum
PEEP were used to provide adequate ventilation and oxy-
genation, to prevent atelectasis and to maintain inspira-
tory plateau pressure <30 cmH2O. Minimum FiO2 was
used to guarantee adequate oxygenation, even in the pres-
ence of CPB. All ventilatory parameters were modified in
accordance with intraoperative analyses. For revasculariza-
tion the internal thoracic artery was used (or bilaterally if
possible) and saphenous vein grafts. Bypass graft flow was
assessed for each graft by Doppler transit time flowmetry.
Protamine was administered to reverse heparin, in accord-
ance to standard practice. For Coronary Artery Bypass
Graft (CABG) surgery, aspirin was routinely administered
within the first 6 h after surgery following the local proto-
col. In all patients, decisions regarding postoperative ICU
management were made by the attending physician. Pa-
tients were treated according to hemodynamic parame-
ters, urine output, metabolic markers of tissue perfusion,
such as arterial lactate levels and venous oxygen satur-
ation, and an individual mechanical ventilation approach
was performed in accordance with respiratory status.
Statistical analyses
Statistical analysis was conducted using PASW statistics
13.0 (SPSS Inc., Chicago, Illinois, USA). Differences regard-
ing PaO2/FIO2 ratios between survivors and non-survivors
were evaluated by means of repeated measures analysis of
variance. Receiver operating characteristic (ROC) curve
analyses were applied to evaluate the predictive power be-
tween different PaO2/FIO2 ratio values and considering
the differences of the areas under the empirical ROC curves
(AUC). In order to determine optimal cut-off values of the
best predictive PaO2/FIO2 ratio value, optimum threshold
estimation was applied.
The optimum threshold was estimated by means of an
adequately weighed cost function, which was then mini-
mized [16]. A confidence interval was also estimated for
this threshold, such that patients with values below the
Figure 1 PaO2/FiO2 ratio levels curve of different measurements
between survivors and non-survivors.
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survivors, patients with values above the upper confidence
interval limit were predicted to be survivors, and values
between the two limits were considered as inconclusive.
Prognostic indexes, such as sensitivity and specificity and
the likelihood ratio for survival were also calculated.
We thus studied all the data based on groups gener-
ated from previous analyses. For comparisons between
groups, post-hoc exploratory analysis comparing differ-
ent baseline and clinical characteristics was performed.
ANOVA (P shown in tables) with post-hoc Bonferroni
correction (P shown in results) was applied in order to
evaluate any differences between the three groups for
the quantitative samples with a normal distribution
(e.g., TnI, ICU stay in hours, etc.). For qualitative vari-
ables (e.g., mortality), the χ2-test test was used. These
differences were confirmed by means of multivariate
analysis after adjusting for preoperative and postopera-
tive scores. The multivariate analysis was a proportional
hazards Cox regression model to evaluate the effect of
staging in the different three groups of PaO2/FIO2 ratio
at 3 h and the differences between the subgroups. Vari-
able selection was performed stepwise and a variable
remained in the model if the p-value was <0.1. Model fit
was assessed through checking residual normality, the
existence and influence of outliers, and goodness-of-fit.
Finally, we evaluated the PaO2/FIO2 ratio as a mortal-
ity risk factor after cardiac surgery analysing differences
between survivors and non-survivors. For this purpose
we categorized PaO2/FIO2 ratios. For comparisons
between groups the Mann–Whitney U test was used or,
when appropriate, the two-sample t-test. The χ2-test
was used to evaluate qualitative variables. Multivariate
analysis was performed based on the previous methods.
Survival analysis was carried out with the Kaplan-Meier
estimator and confirmed by means of the proportional
hazards Cox regression model. The normality of the
quantitative samples was checked by means of the one-
sample Kolmogorov-Smirnov test in all cases, if neces-
sary. Data are expressed as mean ± standard deviation.
A two-tailed p value < 0.05 was considered statistically
significant.Table 1 PaO2/FiO2 ratio levels curve of different measuremen
Survivors (n = 2569; 95.1%)
PaO2/FIO2 ratio on admission 334 ± 95
PaO2/FIO2 ratio at 3 h 329 ± 90
PaO2/FIO2 ratio at 6 h 326 ± 89
PaO2/FIO2 ratio at 12 h 319 ± 94
PaO2/FIO2 ratio at 24 h 316 ± 73
PaO2/FiO2 ratio: Arterial partial pressure of O2 and fraction of inspired oxygen ratioResults
PaO2/FIO2 ratios were higher in survivors than non-
survivors (see Figure 1 and Table 1). ROC curve analysis
showed that the PaO2/FIO2 ratio at 3 h after ICU ad-
mission was the best predictor of ICU mortality, and
was also better than cardiac surgery scores. When com-
paring ROC curves of the PaO2/FIO2 ratio at 3 h with
ICU scores, there were only slight differences, except in
the case of APACHE II which was considerably higher
(see Figure 2 and Table 2).
The optimum threshold estimation explored the value
of the PaO2/FIO2 ratio at 3 h after admission as a pre-
dictor of hospital mortality, giving an optimal cut-off of
222 (95% Confidence interval (CI):202–242). On the basis
of the confidence interval limits, patients were classified
into three groups: patients with a PaO2/FIO2 ratio >241,
corresponding to a high expectation of survival (Group 1);
patients with a PaO2/FIO2 ratio between 202 and 241,
corresponding to an inconclusive outcome (Group 2); and
patients with a PaO2/FIO2 ratio <202, corresponding to
low expectation of survival (Group 3). The results showed
2195 patients with a PaO2/FIO2 ratio >241, 257 with a ra-
tio between 202 and 241, and 249 with a ratio <202. The
accuracy indexes of sensitivity and specificity were 82%ts between survivors and non-survivors
Non-survivors (n = 132; 4.9%) P
303 ± 103 0.001
288 ± 104 <0.001
280 ± 104 <0.001
273 ± 96 0.008
246 ± 86 <0.001
.
Figure 2 Receiver operating characteristic curve analysis for
PaO2/FIO2 at 3 h.
Esteve et al. BMC Anesthesiology 2014, 14:83 Page 4 of 9
http://www.biomedcentral.com/1471-2253/14/83and 21% respectively, and the predictive value for in hos-
pital survival was 96%. The likelihood ratio for survival
was 1.23 (95% CI:1.09-1.39) and for the outcome death
was 0.41 (95% CI:0.29-0.58). These results indicate that
survival is more likely in a patient with a PaO2/FIO2 ratio
higher than 242, and death is more likely in a patient with
a ratio lower than 202.
Baseline demographic and clinical characteristics of dif-
ferent groups (preoperative, intraoperative, and postopera-
tive) are shown in Table 3. Regarding the preoperative data,
Group 2 had a higher percentage of males (Bonferroni
post-hoc: p < 0.001). The incidence of chronic obstructive
bronchopulmonary disease (COPD) was higher in Group 3
(21.7%) than in either Group 2 (17.5%) or Group 1 (9.9%)Table 2 Comparison of area under curve (AUC) for the differe
AUC ± SD% (95% CI) Cut
PaO2/FIO2 ratio on admission 58.8 ± 8.8 (54.6 - 66.9)
PaO2/FIO2 ratio at 3 h 77.2 ± 2.9 (71.2 - 82.8)
PaO2/FIO2 ratio at 6 h 67.3 ± 3.2 (60.9 - 73.6)
PaO2/FIO2 ratio at 12 h 71.1 ± 3.2 (64.9 - 77.6)
PaO2/FIO2 ratio at 24 h 63.4 ± 3.3 (57.0 - 69.8)
EuroSCORE 71.1 ± 4.4 (62.5 - 79.7)
Parsonnet 68.7 ± 5.1 (58.8 - 78.7)
SAPS II 78.5 ± 4 (70.6 - 86.4)
APACHE II 82 ± 3.9 (74.4 - 89.6)
APACHE III 79.6 ± 4.5 (70.8 - 88.4)
PaO2/FiO2 ratio: Arterial partial pressure of O2 and fraction of inspired oxygen ratio
Simplified Acute Physiology Score. APACHE: Acute Physiology and Chronic Health E
Results are expressed as mean ± standard deviation or percentage.
Comparison of area under curve (AUC) for the different PaO2/FIO2 ratios and score(p < 0.001). There was a higher percentage of smokers in
Group 2 (28.4%) than in Group 3 (26.5%) and Group 1
(19.8%) (p < 0.001). Group 3 patients tended to have higher
body mass indices than patients in both groups 2 and 3, al-
though the difference was not significant. Patients in Group
3 had higher preoperative creatinine levels and more
chronic renal failure (CRF) than those in the other two
groups (p = 0.001). As well, TnI levels were higher in Group
3 than among patients in the other two groups (p < 0.001).
Scores on all the prognostic systems (Parsonnet and Euro-
SCORE, SAPS II, APACHE II, APACHE III) were likewise
higher in Group 3.
Regarding outcomes, the mean ICU stay in Group 3 was
4.1 days longer than in Group 2 (p = 0.002) and 6.1 days
longer than in Group 1 (p < 0.001). Similarly, the hospital
stay in Group 3 was 7 days longer by than in Group 2 and
8.1 days longer than in Group 1 (both p < 0.001). Group 3
showed significantly greater in-ICU mortality (χ2 = 25.2,
p < 0.001) and in-hospital mortality (χ2 = 26.2, p < 0.001)
compared with the other two groups. The differences be-
tween groups in terms of mortality and length of stay are
represented in Figure 3. In-ICU mortality was 320%
higher in patients with a PaO2/FIO2 ratio <202 than in
patients with a PaO2/FIO2 ratio >241. The same pattern
was observed for in-hospital mortality, which was 280%
higher in patients with a PaO2/FIO2 ratio <202 compared
with those with a ratio > 241. In addition, both ICU and
hospital stay were longer in patients with a ratio <202 than
in those with a ratio > 241: longer by 6 days for ICU stay
and by 8 days for hospital stay. Finally, regarding respira-
tory complications, Group 2 and 3 also showed higher
rates (see Table 4) with the exception of diaphragmatic
paresis and hemothorax.
Multivariate analysis (see Table 5) confirmed higher
tracheal reintubation rates in Groups 2 and 3 than in
Group 1; higher Acute Pulmonary Edema in Group 3nt PaO2/FIO2 ratios and scores
-off levels Sensitivity Specificity P value
314 63% 58% 0.001
255 81% 69% <0.001
301 61% 68% <0.001
265 70% 64% <0.001
300 62% 57% <0.001
6.5 69.4% 56.3% <0.001
12.5 63.9% 66.4% <0.001
27.5 80.6% 70% <0.001
13.5 72.2% 63.3% <0.001
51.5 75% 62.1% <0.001
. EuroSCORE: European system for cardiac operative risk evaluation. SAPS:
valuation.
s.
Table 3 Baseline demographic and clinical characteristics (preoperative, intraoperative, and postoperative) of patients
PaO2/FIO2 PaO2/FIO2 PaO2/FIO2 p value
ratio > 241 ratio 202-241 ratio < 202
(n = 2195) (n = 257) (n = 249)
Preoperative data
Age 65.3 (11.1) 66.1 (9.6) 66.0 (10.2) 0.392
BMI (kg∙m−2) 27.9 (8.5) 28.8 (4.2) 29.7 (17.5) 0.09
Gender (% male) 60.1 73.5 72.7 < 0.001
HBP (%) 61.8 67.7 66.7 <0.001
IDDM (%) 8.2 9.3 8.0 0.867
NIDDM (%) 17.5 17.9 18.1 0.748
DLP (%) 51.2 56.4 47.8 0.354
Smokers (%) 19.8 28.4 26.5 <0.001
Vasculopathy (%) 8.4 8.9 9.6 0.947
COPD (%) 9.9 17.5 21.7 <0.001
CRF (%) 4.1 5.1 10.4 <0.001
Ejection fraction (%) 60.7 (11.5) 58.7 (13.0) 60.0 (11.9) 0.06
Preoperative haematocrit (%) 39.5 (4.9) 40.5 (5.0) 38.8 (6.0) <0.001
Preoperative platelets (x106/L) 216423 (67126) 213470 (60195) 219409 (79665) 0.615
Preoperative creatinine (μmol/l) 91.8 (48.5) 94.6 (37.1) 107.9 (80.8) <0.001
Parsonnet 10.8 (6.4) 11.5 (8.0) 13.8 (9.9) <0.001
EuroSCORE 5.2 (2.8) 5.5 (3.2) 6.2 (3.6) 0.006
Surgical group
CABG (%) 28.6 35.8 31.1 0.145
Valve (%) 62.7 55.3 60.7 0.145
CABG + Valve (%) 8.7 8.9 8.2 0.145
CPB time (min) 109.9 (36.4) 115.1 (37.6) 118.6 (40.7) <0.001
Cross-clamping time (min) 71.9 (26.6) 73.2 (24.6) 76.0 (29.7) 0.07
Main Postoperative data
SAPS II 22.8 (8.9) 26.4 (9.0) 29.3 (10.4) <0.001
APACHE II 11.7 (4.2) 13.0 (4.8) 14.7 (5.4) <0.001
APACHE III 47.6 (16.2) 52.8 (18.5) 60.8 (20.7) <0.001
Blood lactate at ICU admission (mmol/L) 2.3 (5.6) 2.3 (1.2) 2.4 (1.4) 0.960
TnI at ICU admission (μg/L) 6.5 (7.0) 7.0 (11.8) 9.4 (25.5) <0.001
Need for blood products (units) 1.8 (2.5) 1.4 (2.8) 1.9 (3.1) 0.17
ICU stay (days) 6.4 (9.2) 8.48 (11.6) 12.5 (15.1) <0.001
Hospital stay (days) 23.6 (19.5) 24.7 (18.0) 31.7 (23.0) <0.001
In-ICU exitus (%) 2.6 4.7 8.4 < 0.001
In-hospital exitus (%) 4 6.2 11.2 <0.001
PaO2/FiO2 Arterial partial pressure of O2 and fraction of inspired oxygen ratio, HBP High blood pressure, IDDM Insulin-dependent diabetes mellitus, NIDDM,
Non-insulin-dependent diabetes mellitus, DLP Dyslipidaemia, COPD, Chronic obstructive pulmonary disease, CRF Chronic renal failure, BMI Body Mass Index,
EuroSCORE European system for cardiac operative risk evaluation, SAPS Simplified Acute Physiology Score, APACHE Acute Physiology and Chronic Health
Evaluation, CPB Cardiopulmonary bypass, CABG Coronary artery bypass graft, TnI Troponin I, Data expressed as mean (SD).
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in Group 3. It also confirmed that Group 3 had the
highest in-ICU mortality and ICU length of stay, and
higher CRF and COPD rates than in group 1.When we categorized the presence of a PaO2/FIO2
ratio <202 at 3 h after admission, we confirmed its value as
a predictor of in-ICU mortality (OR: 1.364; 95% CI: 1.212-
1.625, p < 0.001). Kaplan-Meier plots, shown in Figure 4,
Figure 3 Percentage of exitus and stay in PaO2/FiO2 ratio <202
group and PaO2/FiO2 ratio 202–241 group, compared to PaO2/
FiO2 ratio >241 group.
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after admission had the poorest long-term survival over the
hospital stay (Log rank test: p = 0.002), which was con-
firmed by means of multivariate analysis (Adjusted Hazard
ratio: 1.48; 95% CI:1.293 – 1.786; p = 0.004).
Discussion
Using a new method, the optimum threshold estimation
criterion, this study highlights the value of the PaO2/FIO2
ratio as a prognostic indicator after cardiac surgery. The
main findings of our study are the association between
higher in-ICU mortality and length of stay with lower
PaO2/FIO2 ratios.
PaO2/FIO2 values were lower in non-survivors than in
survivors. Furthermore, the ratio has been reported to be
a predictor of mortality in critically ill patients, particularly




Mechanical ventilation (hours) 35 (101)
Hours until tracheal extubation 27.5 (74.1)









PEEP: positive end expiratory pressure. Data expressed as mean (SD).values of the PaO2/FIO2 ratio may be due to pathological
conditions, primarily those of a respiratory nature (atelec-
tasis, ARDS, acute pulmonary edema, pneumonia, etc.), as
well as to alterations in hemodynamic status (cardiogenic
shock, septic shock, etc.), or even both.
Immediately after cardiac surgery it is easy for physi-
cians to detect a low PaO2/FIO2 ratio which can be
swiftly corrected using general ICU procedures, such as
appropriate analgesia, correcting tracheal tube place-
ment if needed, or increasing PEEP to correct intraoper-
ative atelectasis [8]. The same applies to hemodynamic
disturbances. These potentially reversible causes may
confound the immediate evaluation of the patient’s sta-
tus performed on admission. Hence, the PaO2/FIO2
ratio 3 h after ICU admission is the most useful for
prognosis purposes.
The so-called “fast-track”, modifying anesthetic tech-
niques and postoperative sedation protocols, may allow
for early tracheal extubation and, therefore, early ICU
discharge without a significant increase in morbidity or
mortality when correctly applied [17,18]. However, re-
admission after this procedure, though infrequent, pro-
duces a catastrophic increase in both mortality and the
length of ICU stay [19,20]. In our view, the use of the
PaO2/FiO2 ratio may help to minimize these types of
events if specific strategies for weaning from mechanical
ventilation are developed for patients at risk.
Several scoring systems are used to predict outcome in pa-
tients undergoing cardiac surgery, notably the Parsonnet
score and the EuroSCORE [13,14], while for patients admit-
ted to ICUs the SAPS II, APACHE II, and APACHE III are
used [9,21]. Although the Parsonnet score and EuroSCORE
are useful for determining the outcome of patients undergo-
ing cardiac surgery they are both based on preoperative vari-
ables and so do not evaluate intraoperative or postoperativesion after cardiac surgery
PaO2/FIO2 PaO2/FIO2 p value
ratio 202-241 ratio < 202
(n = 257) (n = 249)
59 (136) 125 (200) <0.001
42.8 (86.9) 70.5 (122.9) <0.001









Table 5 Differences between subgroups according PaO2/FIO2 ratio at 3 h after surgery in a multivariate analysis
Hazard ratio (95% CI) P value
PaO2/FIO2 ratio > 241 subgroup vs. PaO2/FIO2 ratio 202–241 subgroup
Preoperative haematocrit (%) 1.080 (1.054 - 1.108) <0.001
Tracheal reintubation 5.338 (1.938 – 14.707) 0.001
ICU stay (days) 1.972 (1.959 - 1.985) <0.001
In-ICU exitus 1.348 (1.185 - 1.654) 0.001
PaO2/FIO2 ratio > 241 subgroup vs. PaO2/FIO2 ratio < 202 subgroup
Acute pulmonary edema 1.636 (1.418 - 1.968) 0.035
Tracheal reintubation 2.649 (1.147 - 6.116) 0.022
Need of tracheostomy 2.121 (1.015 - 4.432) 0.046
ICU stay (days) 1.961 (1.951 - 1.971) <0.001
In-ICU exitus 1.332 (1.206 - 1.536) <0.001
PaO2/FIO2 ratio 202–241 subgroup vs. PaO2/FIO2 ratio < 202 subgroup
Chronic obstructive pulmonary disease 1.031 (1.006 - 1.056) 0.015
Chronic renal failure 1.847 (1.371 - 2.207) 0.005
Need of tracheostomy 2.371 (1.301 - 4.322) 0.005
ICU stay (days) 1.489 (1.319 - 1.602) <0.001
In-ICU exitus 1.190 (1.078 - 1.459) <0.001
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APACHE III are useful in determining the outcome of ICU
patients, but they are only available 24 h after ICU admis-
sion and require the determination of several physiopatho-
logical variables and analytical parameters, including the
PaO2/FIO2 ratio. Therefore, in the immediate postoperative
period physicians lack a prognostic tool other than their
own clinical judgment. In addition, cardiac surgery patients
constitute a specific population of ICU patients with low
mortality and short length of stay; it is therefore crucial
to detect the ones who are at risk of postoperativeFigure 4 Kaplan-Meier survival curves for PaO2/FIO2 ratio <202
at 3 h subgroup.complications and/or death, especially considering the in-
crease in aging and comorbidities in previous years [22].
The presence of preoperative organ dysfunction adversely
affects outcome after cardiac surgery [23]. Minimal changes
in preoperative kidney function are associated with a sub-
stantial increase in the risk of mortality and morbidity fol-
lowing cardiac surgery, even when increases in serum
creatinine levels are minimal [24]. In addition, during Car-
diopulmonary Bypass (CPB) the kidneys may suffer from
an imbalance between oxygen supply and oxygen needs,
resulting in inadequate oxygen delivery that can be associ-
ated with worsening of renal function [25]. In addition, the
presence of COPD entails a variable degree of airway in-
flammation which may be aggravated by CPB [26]. Both
COPD and CRF show a consistent trend of increasing fre-
quency of postoperative complications with advanced dis-
ease [23]; the higher incidences of both chronic diseases in
the PaO2/FIO2 group with the worst survival may be re-
lated to this.
Respiratory complications are frequent reasons for ICU
readmission and increase length of stay and mortality [27].
In consequence, our findings for respiratory complications
are not surprising, especially if we consider PaO2/FIO2
ratio as a reflection of respiratory status. Tracheal reintu-
bation worsens outcomes, increasing both complications
and mortality [28]. The higher risk of tracheal reintuba-
tion in the groups with lower PaO2/FIO2 ratios may pro-
mote the use of the ratio as an assessment tool in tracheal
extubation and/or weaning strategies. Early tracheostomy
in patients who require prolonged mechanical ventilation
after cardiac surgery is associated with decreased length of
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strategy in the case of a persistently low PaO2/FIO2 ratio
after an individual approach.
It was not the purpose of our study to differentiate be-
tween causative conditions of low PaO2/FIO2 ratio. Our
results do not specifically address the cause of a low
PaO2/FIO2 ratio in patients after cardiac surgery (which
may represent a limitation of the study), but serve to
evaluate the outcome in this scenario. Our study has
other limitations as well. The most important is that it
was a single-centre, observational study. However, it was
conducted at a large tertiary referral hospital with a high
level of complexity which performs all types of cardiac
surgery and has a referral population of almost 2 million.
Among the strengths of this study are its large sample
size (the largest to date in studies addressing the postop-
erative PaO2/FIO2 ratio) and the prospective design.
Our results may be clinically relevant, since a simple de-
termination of PaO2/FIO2 ratio may provide very im-
portant information for determining outcome, both in
terms of mortality and length of stay, in the immediate
postoperative care of cardiac surgery patients. In addition,
this strategy may be applicable in other post-cardiac sur-
gery ICU settings because all the procedures and measure-
ments are routine in clinical practice and easy to obtain.
Conclusions
In summary, the PaO2/FIO2 ratio may be useful for identi-
fying cardiac surgery patients at risk in the immediate post-
operative period. PaO2/FIO2 ratios are lower in patients at
risk, and the values at 3 h after admission are the most use-
ful in terms of predicting in-ICU outcome. Respiratory
complications are more frequent with PaO2/FIO2 ratios
lower than 241. A simple determination of PaO2/FIO2 ra-
tio at 3 h may provide important information about patient
status. Physicians should be alert to the presence of low
values, especially PaO2/FIO2 ratios at 3 h below 202.
Key messages
 The PaO2/FIO2 ratio may be useful to identify at
risk cardiac surgery patients in the immediate
postoperative period.
 The PaO2/FIO2 ratio at 3 h after ICU admission has
the highest prediction power in terms of outcome.
 Respiratory complications are more frequent when
the PaO2/FIO2 ratio at 3 h is lower than 241 and
poor outcome when the ratio below 202.
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